SafeTy and Outcome of contemPorary Treatment Strategies for Cardiogenic SHOCK

NCT03313687 · tracked via the Priya Life Science Germany tracker

Sponsor

Universitätsklinikum Hamburg-Eppendorf

Phase

Observational

Started

2017-09-01

Last updated

2021-10-07

Condition(s) studied

Cardiogenic Shock

Study summary

International, observational registry to investigate the outcome in patients with cardiogenic shock. The primary aim of this study is to investigate the clinical outcome of patients in cardiogenic shock.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Patients with cardiogenic shock treated at a tertiary care hospital. Exclusion Criteria: * Age ≤17 years.

Primary outcome measure(s)

All-cause mortality — Within 30 days after admission.
by registration office

Trial sites (1)

Facility	City	Region	Status
University Heart Center	Hamburg	Germany	Recruiting

More Universitätsklinikum Hamburg-Eppendorf trials in Germany

External Validation of the MASCAN Score for the Classification of Difficult Mask Ventilation Recruiting

Characterisation of phenotYpes in aCute Heart faiLure patiEnts Recruiting

Prospective Registry and Biobank for Long-term Observational Studies in Adult Patients with Pulmonary Hypertension Recruiting

Proof of Concept Human Study: Dietary Intervention to Modify Intestinal Inflammation in IBD Active, not recruiting

Cerebellar Transcranial Alternating Current Stimulation (tACS) to Modulate Parkinson's Disease Tremor Recruiting

Other trials for the same condition

Characterisation of phenotYpes in aCute Heart faiLure patiEnts Recruiting

Abiomed Impella RT-DAQ - Observational Study Recruiting

Correlation of Cardiac Output Determined by Echocardiography and Indirect Calorimetry in Critically Ill Patients in Cardiogenic Shock on Extracorporeal Circulatory Life Support Recruiting

Multimodal Phenotyping In Patients Referred With Acute Cardiac faiLurE Recruiting

Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic Shock Starting soon

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT03313687 on ClinicalTrials.gov ↗ ← All trials in Germany